As discussed earlier, the program does not use compounded semaglutide, tirzepatide, or similar agents due to concerns about purity, potency, and regulatory oversight
The most common adverse effects associated with GLP-1 medications are gastrointestinal in nature, including nausea, vomiting, diarrhea, constipation, and abdominal discomfort
Structural Characteristics Cagrilintide retains the 37-amino acid backbone length of native amylin but incorporates multiple strategic modifications
H.BerndtC.HolmgrenA
Extending beyond fetal safety, in a cohort of nearly 4,300 women who received GLP-1RA therapy within two years prior to conception, exposure was associated with a lower risk of developing gestational diabetes mellitus and hypertensive disorders of pregnancy 14